Literature DB >> 11050619

Rho proteins and the cellular mechanisms of mental retardation.

G J Ramakers1.   

Abstract

The biological basis of mental retardation is poorly understood. Mental retardation is associated with an immature morphology of synaptic spines, structures involved in neurotransmission and memory processes, suggesting that mental retardation is due to a deficiency in neuronal network formation. Recently, several genes involved in X-linked mental retardation (MRX) have been cloned. Investigation of the roles of these genes in neuronal development and function should lead to a better understanding of the cellular mechanisms underlying mental retardation. A significant number of MRX genes is directly involved in signal transduction through Rho proteins. These Rho proteins act as molecular switches which integrate extracellular and intracellular signals to regulate rearrangement of the actin cytoskeleton. Since the actin cytoskeleton mediates neuronal motility and morphogenesis, one can envision how mutations in proteins involved in Rho-dependent signaling result in mental retardation by altering neuronal network formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050619     DOI: 10.1002/1096-8628(20001023)94:5<367::aid-ajmg4>3.0.co;2-i

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

2.  Reduced cortical folding in mental retardation.

Authors:  Y Zhang; Y Zhou; C Yu; L Lin; C Li; T Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 3.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Synaptic plasticity, a symphony in GEF.

Authors:  Drew D Kiraly; Jodi E Eipper-Mains; Richard E Mains; Betty A Eipper
Journal:  ACS Chem Neurosci       Date:  2010-05-19       Impact factor: 4.418

5.  Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.

Authors:  Sarah A Shoichet; Laurence Duprez; Olivier Hagens; Vicki Waetzig; Corinna Menzel; Thomas Herdegen; Susann Schweiger; Bernard Dan; Esther Vamos; Hans-Hilger Ropers; Vera M Kalscheuer
Journal:  Hum Genet       Date:  2005-10-25       Impact factor: 4.132

Review 6.  ECM receptors in neuronal structure, synaptic plasticity, and behavior.

Authors:  Meghan E Kerrisk; Lorenzo A Cingolani; Anthony J Koleske
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

7.  Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases.

Authors:  Eva Marie Yang Moresco; Stephanie Donaldson; Anne Williamson; Anthony J Koleske
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

8.  Integrin α3 is required for late postnatal stability of dendrite arbors, dendritic spines and synapses, and mouse behavior.

Authors:  Meghan E Kerrisk; Charles A Greer; Anthony J Koleske
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

9.  Kalirin-7 is required for synaptic structure and function.

Authors:  Xin-Ming Ma; Drew D Kiraly; Eric D Gaier; Yanping Wang; Eun-Ji Kim; Eric S Levine; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation.

Authors:  Volker Endris; Birgit Wogatzky; Uwe Leimer; Dusan Bartsch; Malgorzata Zatyka; Farida Latif; Eamonn R Maher; Gholamali Tariverdian; Stefan Kirsch; Dieter Karch; Gudrun A Rappold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.